Additionally, the mutation analysis indicated that mutations in the SLC39A4 gene have a significant and wide-ranging effect on DF, OS, and PFS in cancer patients, particularly in those with PAAD. The gene discussed is SLC39A4; the disease is pancreatic adenocarcinoma.